Skip to main content

Sonoco ThermoSafe’s New Pegasus ULD® Receives FAA Approval

ARLINGTON HEIGHTS, Ill., Sept. 15, 2020 (GLOBE NEWSWIRE) — Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON) and the leading global provider of temperature assurance packaging for life sciences and healthcare, announced that its new Pegasus ULD® bulk temperature controlled container has received FAA (Federal Aviation Administration) approval as a unit load device (ULD). 
The Pegasus ULD® is the world’s first passive bulk temperature-controlled container for pharmaceutical use that is an FAA-approved unit load device, which allows it to speed through existing international ground handling and customs processes at the lowest possible cost. FAA approval officially enables reciprocal EASA (European Aviation Safety Agency) approval, which is anticipated in the very near future. Engineered with composite materials, the Pegasus ULD® will offer a lighter solution that is substantially more damage-resistant than traditional metal containers. Additionally, the Pegasus contains a fully integrated, FAA (Federal Aviation Administration) approved telemetry system, providing real-time, cloud-based data on payload and ambient temperature and key environmental factors, precisely synchronized with GPS location. To create the Pegasus ULD, Sonoco ThermoSafe signed a long-term exclusive development and manufacturing agreement with AEROTUF, a leading supplier of innovative composite ULD containers (www.aerotuf.com). The partnership combines ThermoSafe’s expertise in thermal engineering and pharmaceutical logistics with AEROTUF’s materials science and aeronautical engineering capabilities. The first Pegasus ULD will be the AKP size, which fits a full US pallet and shares the same footprint of the AKE size without the imbalanced overhang section which accounts for over 80% of transit damage in AKE/RKN containers.“FAA approval of our new Pegasus ULD® is an important milestone and puts us another step closer to our launch date for the rental program,” said Ron Haub, Segment Director for Sonoco ThermoSafe. “This approval accelerates the adoption of the Pegasus ULD across the worldwide air freight marketplace during the world’s most dire need for distribution of temperature-sensitive vaccines, treatments, and therapies.”Visit https://www.thermosafe.com/pegasus-uld to learn more.About Sonoco ThermoSafe
Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON), is a leading global provider of temperature assurance packaging for the safe and efficient transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products. Sonoco ThermoSafe shipping solutions mitigate risk for customers and ensure product efficacy throughout the extremes of a supply chain. With operations in the Americas, Europe and Asia, Sonoco ThermoSafe has a vast product offering featuring industry-leading technology that encompasses refrigerated, frozen or controlled room temperature applications. In addition, Sonoco ThermoSafe’s ISC Labs® deliver individualized design and testing services and innovative packaging solutions along with qualification and validation services to meet all regulatory requirements. More information can be found at www.thermosafe.com.
About Sonoco
Founded in 1899, Sonoco (NYSE: SON) is a global provider of a variety of consumer packaging, industrial products, protective packaging, and displays and packaging supply chain services. With annualized net sales of approximately $5 billion, the Company has 21,000 employees working in more than 300 operations in 33 countries, serving some of the world’s best known brands in some 85 nations. Sonoco is committed to Better Packaging. Better Life., and ranked first in the Packaging sector on Fortune’s World’s Most Admired Companies 2018-2019-2020 list. For more information visit www.sonoco.com.
Contact:
Brian Risinger
+843-383-7509

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.